Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026
Proton Pump Inhibitor Use Was Not Associated With Reduced Gastrointestinal Bleeding Risk in Ischemic Stroke Patients Treated With Dual Antiplatelet Therapy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Xinyu, Zhou Zhenfeng, Teng Jijun, Fan Xuebin, Zhang Chunhua, Wang Sanqi, Su Xiaohang, Liu Zongchao
Аннотация
BACKGROUND: To evaluate the association between proton pump inhibitor (PPI) use and gastrointestinal bleeding (GIB) in acute ischemic stroke (AIS) patients receiving dual antiplatelet therapy (DAPT).
METHODS: This retrospective study analyzed 3,122 AIS patients with large artery atherosclerosis (LAA) treated with DAPT at Qingdao University Affiliated Hospital (September 2020-December 2023). Adjusted odds ratios (aORs) for GIB were calculated using binary logistic regression, controlling for confounders including age, sex, and other baseline characteristics. To address confounding by indication, we additionally performed 1:1 propensity score matching (PSM) as a sensitivity analysis, with conditional logistic regression applied to the matched cohort.
RESULTS: 45.0% (n=1,404) received concomitant PPI. No significant difference in GIB incidence was observed between PPI users and non-PPI users (2.1% vs. 1.3%, p = 0.12). Subgroup analyses revealed that PPI use was significantly associated with increased GIB risk in non-endovascular therapy patients (aOR = 2.08, p = 0.03), particularly those with posterior circulation infarction (aOR = 5.96, p = 0.006). These findings were further supported by propensity score matching analysis (conditional OR = 1.64, 95% CI 0.87-3.09, p = 0.124 for the overall cohort; conditional OR = 12.29, 95% CI 1.59-94.90, p = 0.016 for posterior circulation infarction in the non-endovascular subgroup). No significant association between PPI use and GIB risk was found in endovascular therapy or age-stratified subgroups.
CONCLUSION: PPI use was not associated with reduced overall GIB risk in DAPT-treated AIS patients. Routine PPI prophylaxis may be unnecessary for low-bleeding-risk populations, while the association observed in posterior circulation infarction remains hypothesis-generating and warrants prospective validation.
METHODS: This retrospective study analyzed 3,122 AIS patients with large artery atherosclerosis (LAA) treated with DAPT at Qingdao University Affiliated Hospital (September 2020-December 2023). Adjusted odds ratios (aORs) for GIB were calculated using binary logistic regression, controlling for confounders including age, sex, and other baseline characteristics. To address confounding by indication, we additionally performed 1:1 propensity score matching (PSM) as a sensitivity analysis, with conditional logistic regression applied to the matched cohort.
RESULTS: 45.0% (n=1,404) received concomitant PPI. No significant difference in GIB incidence was observed between PPI users and non-PPI users (2.1% vs. 1.3%, p = 0.12). Subgroup analyses revealed that PPI use was significantly associated with increased GIB risk in non-endovascular therapy patients (aOR = 2.08, p = 0.03), particularly those with posterior circulation infarction (aOR = 5.96, p = 0.006). These findings were further supported by propensity score matching analysis (conditional OR = 1.64, 95% CI 0.87-3.09, p = 0.124 for the overall cohort; conditional OR = 12.29, 95% CI 1.59-94.90, p = 0.016 for posterior circulation infarction in the non-endovascular subgroup). No significant association between PPI use and GIB risk was found in endovascular therapy or age-stratified subgroups.
CONCLUSION: PPI use was not associated with reduced overall GIB risk in DAPT-treated AIS patients. Routine PPI prophylaxis may be unnecessary for low-bleeding-risk populations, while the association observed in posterior circulation infarction remains hypothesis-generating and warrants prospective validation.